FINWIRES · TerminalLIVE
FINWIRES

バンク・オブ・アメリカは、カナディアン・ナショナル鉄道の輸送量データは予想を上回るペースで推移すると予測していると述べた。

-- バンク・オブ・アメリカ証券はレポートの中で、カナディアン・ナショナル鉄道(CNI)は輸送量増加の予測を上回り、市場シェアを拡大しているようだと述べた。 バンク・オブ・アメリカのアナリスト、ケン・ホエクスター氏は木曜日に送付したレポートの中で、同社の主要貨物輸送指標である収益トンマイルは、「記録的なカナダの穀物収穫量の増加と、目標を上回る複合一貫輸送および自動車輸送量に支えられ、同社の年間目標である横ばいを大きく上回っている」と指摘した。 カナディアン・ナショナル鉄道は4月29日に第1四半期決算を発表する予定だ。 同証券は、10月に最高執行責任者(COO)に就任したパトリック・ホワイトヘッド氏の下、同社のサービス指標も改善していると付け加えた。 バンク・オブ・アメリカはカナディアン・ナショナル鉄道の投資判断を「中立」から「買い」に引き上げ、目標株価を117ドルから122ドルに引き上げた。 同社の株価は年初来11%上昇しており、ホエクスター氏はさらなる上昇余地があると指摘している。 「穀物の先行取引の動きを考慮すると、基礎的な取引量は(第2四半期に)減速する可能性があるが、構成比の影響、約1年前の炭素税収入の喪失、燃料サーチャージの遅延効果を考慮すると、マイナスの収益が見込まれる」とホークスター氏は述べた。

Price: $110.15, Change: $+0.01, Percent Change: +0.01%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB